NorthWest Biotherapeutics Inc (NWBO)

[Horseb4CarT]

As I’ve opined previously, the focus is on the goal of DCVax approval, and although management may care about common shareholders, we are secondary at best and somewhat fungible (proper usage?) if deemed necessary to advance the primary goal.

I’ve long felt that way and accepted the prospect of some collateral damage.

In any event I think we are past the collateral damage phase unless we get a big dilutive financing, which I think has been avoided recently.